Inventor of Noninvasive Stool DNA Test for Early Detection of Colorectal Cancer

Dr Hongzhi Zou CEO /Founder

  • Global Inventor of Noninvasive sDNA Test for Early Detection of Colorectal Cancer

  • Founder of Creative Biosciences (Guangzhou) Co., Ltd

  • Colosafe® was awarded one of the Ten Advanced Medical & Biological Technologies in China in 2018.

  • 2002 PHD degree from Dept of Surgery, Ruijin Hospital; Post doctoral work at Mayo Clinic to start his dedication in sDNA testing.

  • 2009 Obtained multiple intellectual property rights of stool DNA testing and became R&D director at Exact Sciences

  • 2012 Developed Cologuard, the world’s first stool DNA test kit for colorectal cancer

  • 2014 Cologuard clinical trial finished in April, FDA approval in August, included in health insurance reimbursement plan on the same day.

  • 2015 Foundation of Creative Biosciences (Guangzhou) Co., Ltd

  • 2018 November 20, Colosafe® was approved by NMPA